Tributary Capital Management, LLC Harmony Biosciences Holdings, Inc. Transaction History

Tributary Capital Management, LLC

  • $1.29 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 17, 2023
SELL
$30.5 - $37.4 $113,612 - $139,315
-3,725 Reduced 1.77%
206,218 $7.26 Million
Q1 2023

Apr 26, 2023
BUY
$30.8 - $53.92 $2.51 Million - $4.4 Million
81,518 Added 63.48%
209,943 $6.85 Million
Q4 2022

Jan 27, 2023
BUY
$45.4 - $60.91 $5.83 Million - $7.82 Million
128,425 New
128,425 $7.08 Million

Others Institutions Holding HRMY

# of Institutions
242
Shares Held
45.1M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.08B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Tributary Capital Management, LLC Portfolio

Follow Tributary Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tributary Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tributary Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email